Related Experiment Video
Updated: Jun 6, 2026
07:17
Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
Published on: April 14, 2016
Nephrolithiasis-associated bone disease: pathogenesis and treatment options.
Khashayar Sakhaee1, Naim M Maalouf, Rajiv Kumar
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8885, USA. Khashayar.sakhaee@utsouthwestern.edu
Kidney International
|December 3, 2010
Summary
Nephrolithiasis (kidney stones) is linked to increased fracture risk and bone density loss. Further research is needed to understand the connection and effective treatments for bone disease in kidney stone patients.
Area of Science:
- Nephrology
- Metabolic Bone Disease
Background:
- Nephrolithiasis is a global health issue with a significant, yet under-recognized, association with bone disease.
- Epidemiological data indicate a higher incidence of osteoporotic fractures in patients with kidney stones compared to the general population.
- Calcium nephrolithiasis patients frequently exhibit decreased bone mineral density and impaired bone remodeling.
Purpose of the Study:
- To review the current understanding of bone disease in nephrolithiasis patients.
- To explore the epidemiology, pathophysiology, and potential therapeutic strategies for bone complications associated with kidney stones.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of pathophysiological mechanisms linking kidney stones and bone defects.
- Evaluation of existing and potential treatments for bone disease in stone formers.
Main Results:
- Patients with nephrolithiasis experience more frequent osteoporotic fractures.
- Common findings in calcium stone formers include reduced bone mineral density and bone remodeling defects.
- The pathophysiological link between kidney stones and bone disease remains unclear.
- While treatments like thiazide diuretics and alkali are used for stone prevention, their efficacy in preventing bone loss in calcium stone formers is unexamined.
Conclusions:
- Bone disease is a critical comorbidity in nephrolithiasis that requires further investigation.
- Understanding the pathophysiology is key to developing targeted treatments for bone loss in kidney stone patients.
- There is a need for clinical trials to assess the effectiveness of current and novel therapies in managing bone health in individuals with nephrolithiasis.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
01:25Urinary Tract Calculi VI: Surgical Management
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
01:28Urinary Tract Calculi I: Introduction
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
01:28Urinary Tract Calculi V: Nursing Management
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...